Trial Profile
A Randomized, Double-Blind, Active- and Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Tapentadol Immediate-Release Formulation in the Treatment of Acute Pain From Bunionectomy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Jun 2014
Price :
$35
*
At a glance
- Drugs Tapentadol (Primary) ; Oxycodone
- Indications Postoperative pain
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Janssen Research & Development
- 05 May 2008 Actual start date (Jan 2008) added as reported by ClinicalTrials.gov.
- 05 May 2008 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 12 Mar 2008 Planned end date (1 Oct 2008) added as reported by ClinicalTrials.gov.